Magdeleine Hung
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Clinical targeting of HIV capsid protein with a long-acting small molecule(2020)403 cited
- → PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection(2018)271 cited
- → Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design(2010)224 cited
- → A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model(2019)160 cited
- → New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action(2012)159 cited
- → Importance of Ribosomal Frameshifting for Human Immunodeficiency Virus Type 1 Particle Assembly and Replication(1998)129 cited
- → Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9(2017)120 cited
- → Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B(2019)92 cited
- → Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B(2020)69 cited
- → Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV(2020)62 cited